CA AB375

Establishes that hospital employees providing direct patient care in acute care hospitals can claim workers' compensation for bloodborne infectious diseases or MRSA that develop during employment.

Creates a disputable presumption that these diseases arise out of and in the course of employment, meaning the employee does not bear the burden of proving workplace origin unless the employer presents contrary evidence.

Extends the presumption protection for 180 days following termination for bloodborne infectious diseases and 90 days following termination for MRSA, commencing with the last date of employment.

Ensures compensation includes full hospital, surgical, and medical treatment, disability indemnity, and death benefits as provided under workers' compensation law.

Defines "bloodborne infectious disease" as disease caused by exposure to pathogenic microorganisms in human blood and limits applicability to acute care hospitals as defined in Health and Safety Code sections 1250(a) or (b).